Elly Ryu
Nessuna posizione attualmente
Patrimonio netto: 17 128 $ in data 31/03/2024
Profilo
Elly Ryu formerly worked at Spectrum Pharmaceuticals, Inc., as Director-Accounting & Accounting from 2017 to 2019, Acrotech Biopharma LLC, as Director-Finance & Accounting in 2019, Sesen Bio, Inc., as Chief Accounting Officer & Controller from 2021 to 2023, and Skillz, Inc., as Chief Accounting Officer & Controller in 2023.
Ms. Ryu received her Masters Business Admin degree from the University of California, Irvine and undergraduate degree from Sogang University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 02/03/2023 | 7 431 ( 0.02% ) | 16 868 $ | 31/03/2024 | |
SKILLZ INC. CLASS A
0.00% | 05/07/2023 | 40 ( 0.00% ) | 260 $ | 31/03/2024 |
Precedenti posizioni note di Elly Ryu
| Società | Posizione | Fine |
|---|---|---|
| SKILLZ INC. | Comptroller/Controller/Auditor | 08/09/2023 |
| CARISMA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/03/2023 |
Acrotech Biopharma LLC
 Acrotech Biopharma LLC Pharmaceuticals: MajorHealth Technology Acrotech Biopharma LLC manufactures generic pharmaceuticals. The company is headquartered in United States. | Director of Finance/CFO | 01/11/2019 |
| SPECTRUM PHARMACEUTICALS, INC. | Director of Finance/CFO | 01/03/2019 |
Formazione di Elly Ryu
| University of California, Irvine | Masters Business Admin |
| Sogang University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SPECTRUM PHARMACEUTICALS, INC. | Health Technology |
| SKILLZ INC. | Technology Services |
| Aziende private | 2 |
|---|---|
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
Acrotech Biopharma LLC
Acrotech Biopharma LLC Pharmaceuticals: MajorHealth Technology Acrotech Biopharma LLC manufactures generic pharmaceuticals. The company is headquartered in United States. | Health Technology |
- Borsa valori
- Insiders
- Elly Ryu
